Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kamil Dyrka"'
Autor:
Kamil Dyrka, Agata Czarnywojtek, Magdalena Borowska, Jeremi Kościński, Jakub Moskal, Nadia Sawicka-Gutaj, Agnieszka Lewandowska, Stefaan Van Gool, Marta Fichna, Paweł Gut, Krzysztof Pietrończyk, Patryk Graczyk, Marzena Dworacka
Publikováno v:
Acta Poloniae Pharmaceutica - Drug Research. 79:763-775
TMZ has an advantage over other traditional alkylating agents (carmustine, lomustine, procarbazine), which are highly toxic and have poor patient survival. TMZ circumvents these problems because cytochrome P450 enzymes and the kidneys are not involve
Autor:
Kamil Dyrka, Lukasz Dzialach, Marek Niedziela, Katarzyna Jonczyk-Potoczna, Katarzyna Derwich, Monika Obara-Moszynska
Background: Central diabetes insipidus (CDI) is a rare disorder in the pediatric population resulting from antidiuretic hormone (ADH) deficiency and caused by several underlying conditions. It is characterized by the excessive production of dilute ur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed4de7a3cae48fa9fd1c6adad2acbfa7
https://doi.org/10.21203/rs.3.rs-2355492/v1
https://doi.org/10.21203/rs.3.rs-2355492/v1
Publikováno v:
Postępy Higieny i Medycyny Doświadczalnej. 75:317-327
Summary Cancer is one of the main causes of mortality worldwide. Thanks to scientific research, new methods of cancer treatment, including molecularly targeted therapy, are being developed. Monoclonal antibodies are used to treat many diseases, inclu
Publikováno v:
Journal of Pediatric Endocrinology and Metabolism. 33:1363-1372
Short stature, ovarian dysgenesis, infertility, and cardiovascular malformations are classic features in Turner syndrome (TS), but the phenotypical spectrum is wide. Through early diagnosis and appropriate treatment, TS patients have a chance to achi
Publikováno v:
Postępy Higieny i Medycyny Doświadczalnej, Vol 73, Pp 491-507 (2019)
Viruses cause many diseases in humans, from self-resolving diseases to acute fatal diseases. New antiviral drugs are registered and the efficacy and safety of other medicines are evaluated in clinical trials. Antiviral therapy significantly reduces t
Publikováno v:
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 48(285)
Viral infections lead to many disorders with a different course and prognosis. Clinical trials are ongoing on new groups of antiviral drugs, which are very promising. However, treatment with antiviral drugs causes numerous adverse effects (AEs) inclu